Stitch Fix (SFIX) Anthony Bacos Exercises Options and Sells Shares

What Happened

• Anthony Bacos, Chief Product/Technology Officer at Stitch Fix (SFIX), reported option exercise(s) and open‑market sales on July 27, 2026. He exercised 50,000 shares at $2.48 (cost $124,000) and a separate derivative conversion of 50,000 shares reported at $0.00. On the same date he sold 50,000 shares (weighted avg $3.77) for $188,705 and 20,000 shares (weighted avg $3.74) for $74,778, for total sale proceeds of about $263,483. Sales are typically viewed as routine liquidity transactions; purchases are generally considered more bullish.

Key Details

• Transaction date: July 27, 2026.
• Exercised/converted: 50,000 shares @ $2.48 (Acquired) = $124,000; another 50,000 reported as conversion @ $0.00 (Derivative).
• Sold: 50,000 shares at a weighted avg $3.77 (proceeds $188,705; prices ranged $3.65–$3.825) and 20,000 shares at weighted avg $3.74 (proceeds $74,778; prices ranged $3.645–$3.765). Total proceeds ≈ $263,483.
• Plan/notes: Sales were made pursuant to a Rule 10b5‑1 plan entered March 17, 2026 (footnote F1). Footnotes F2/F3 provide per‑trade price ranges and the reporting person’s undertaking to disclose per‑price quantities on request. Footnote F4 describes the option vesting schedule (25% vested June 12, 2024; remaining vest in specified quarterly installments).
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Filing timeliness: no late filing indicated in the provided information.

Context

• The filing shows exercises and open‑market sales on the same date. That pattern is commonly a cashless exercise or an immediate sale to cover option costs/taxes, but the Form 4 does not state the parties’ purposes. The presence of a 10b5‑1 plan indicates the sales were pre‑arranged trading instructions rather than ad hoc trades. As always, these reports are factual disclosures and do not by themselves indicate the insider’s broader view of the company.